Annual Shareholders Equity
$61.86 M
-$13.26 M-17.65%
31 December 2023
Summary:
Zevra Therapeutics annual stockholders equity is currently $61.86 million, with the most recent change of -$13.26 million (-17.65%) on 31 December 2023. During the last 3 years, it has risen by +$128.28 million (+193.15%). ZVRA annual shareholders equity is now -51.33% below its all-time high of $127.12 million, reached on 31 December 2021.ZVRA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$69.77 M
+$37.29 M+114.82%
30 September 2024
Summary:
Zevra Therapeutics quarterly stockholders equity is currently $69.77 million, with the most recent change of +$37.29 million (+114.82%) on 30 September 2024. Over the past year, it has increased by +$2.30 million (+3.41%). ZVRA quarterly shareholders equity is now -47.04% below its all-time high of $131.74 million, reached on 01 September 2021.ZVRA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.6% | +3.4% |
| 3 y3 years | +193.2% | -47.0% |
| 5 y5 years | +192.9% | +198.8% |
ZVRA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -51.3% | +193.2% | -47.0% | +114.8% |
| 5 y | 5 years | -51.3% | +183.1% | -47.0% | +193.7% |
| alltime | all time | -51.3% | +183.1% | -47.0% | +173.2% |
Zevra Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $69.77 M(+114.8%) |
| June 2024 | - | $32.48 M(-33.5%) |
| Mar 2024 | - | $48.82 M(-21.1%) |
| Dec 2023 | $61.86 M(-17.6%) | $61.86 M(-8.3%) |
| Sept 2023 | - | $67.47 M(-1.5%) |
| June 2023 | - | $68.50 M(-4.1%) |
| Mar 2023 | - | $71.40 M(-4.9%) |
| Dec 2022 | $75.12 M(-40.9%) | $75.12 M(-19.9%) |
| Sept 2022 | - | $93.79 M(-5.5%) |
| June 2022 | - | $99.23 M(-18.3%) |
| Mar 2022 | - | $121.50 M(-4.4%) |
| Dec 2021 | $127.12 M(-291.4%) | - |
| Dec 2021 | - | $127.12 M(-3.5%) |
| Sept 2021 | - | $131.74 M(+0.8%) |
| June 2021 | - | $130.66 M(+55.1%) |
| Mar 2021 | - | $84.25 M(-226.9%) |
| Dec 2020 | -$66.41 M(-10.8%) | -$66.41 M(+6.6%) |
| Sept 2020 | - | -$62.33 M(-0.9%) |
| June 2020 | - | -$62.86 M(-8.5%) |
| Mar 2020 | - | -$68.67 M(-7.8%) |
| Dec 2019 | -$74.46 M | -$74.46 M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -$70.62 M(-13.4%) |
| June 2019 | - | -$81.55 M(+9.0%) |
| Mar 2019 | - | -$74.84 M(+12.4%) |
| Dec 2018 | -$66.57 M(+15.7%) | -$66.57 M(-30.2%) |
| Sept 2018 | - | -$95.34 M(+14.1%) |
| June 2018 | - | -$83.55 M(+4.8%) |
| Mar 2018 | - | -$79.68 M(+38.5%) |
| Dec 2017 | -$57.52 M(+207.6%) | -$57.52 M(+19.6%) |
| Sept 2017 | - | -$48.10 M(+22.5%) |
| June 2017 | - | -$39.28 M(+15.8%) |
| Mar 2017 | - | -$33.93 M(+81.5%) |
| Dec 2016 | -$18.70 M(+84.7%) | -$18.70 M(+90.7%) |
| Sept 2016 | - | -$9.80 M(-3043.5%) |
| June 2016 | - | $333.00 K(-102.9%) |
| Mar 2016 | - | -$11.48 M(+13.4%) |
| Dec 2015 | -$10.12 M(-79.1%) | -$10.12 M(+76.1%) |
| Sept 2015 | - | -$5.75 M(-265.9%) |
| June 2015 | - | $3.46 M(-106.4%) |
| Mar 2015 | - | -$54.35 M(+12.0%) |
| Dec 2014 | -$48.51 M(+99.9%) | -$48.51 M |
| Dec 2013 | -$24.27 M | - |
FAQ
- What is Zevra Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Zevra Therapeutics?
- What is Zevra Therapeutics annual shareholders equity year-on-year change?
- What is Zevra Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly shareholders equity year-on-year change?
What is Zevra Therapeutics annual stockholders equity?
The current annual shareholders equity of ZVRA is $61.86 M
What is the all time high annual shareholders equity for Zevra Therapeutics?
Zevra Therapeutics all-time high annual stockholders equity is $127.12 M
What is Zevra Therapeutics annual shareholders equity year-on-year change?
Over the past year, ZVRA annual stockholders equity has changed by -$13.26 M (-17.65%)
What is Zevra Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ZVRA is $69.77 M
What is the all time high quarterly shareholders equity for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly stockholders equity is $131.74 M
What is Zevra Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ZVRA quarterly stockholders equity has changed by +$2.30 M (+3.41%)